Author

I. Bello-Rivero

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Hardy-Sosa· 1 shared D. Vazquez-Blomquist· 1 shared J. R. Wisniewski· 1 shared L. J. Gonzalez· 1 shared O. Guirola· 1 shared S. C. Baez· 1 shared S. Palomares· 1 shared V. Besada· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Hardy-Sosa

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Proteomics and phosphoproteomics profiling of the co-formulation of type I and II interferons, HeberFERON, in the glioblastoma-derived cell line U-87 MG

D. Vazquez-Blomquist, A. Hardy-Sosa, S. C. Baez, V. Besada, S. Palomares, O. Guirola, Y. Ramos, J. R. Wisniewski, L. J. Gonzalez, I. Bello-Rivero

This study uses proteomic and phosphoproteomic analyses to investigate the effects of HeberFERON on U-87 MG glioblastoma cells, identifying key pathways and phosphosites involved in antiproliferative responses.

bioRxiv · Oct 3, 2022 · PreprintCancer Biology